Exhaled nitric oxide as a marker of diseases;Il ruolo della misura del monossido di azoto nell'aria espirata in patologia

Recenti Progressi in Medicina

Volumn 96, Issue 12, 2005, Pages 634-640

  Rolla, Giovanni ^a   Heffler, Enrico ^a   Bommarito, Luisa ^a   Bergia, Roberta ^a   Ferrero, Nicoletta ^a  

^a MAURIZIANO HOSPITAL   (Italy)

Author keywords

Asthma; Exhaled nitric oxide; Hepatopulmonary syndrome; Interstitial lung diseases

Indexed keywords

CORTICOSTEROID; NITRIC OXIDE; STEROID;

ASTHMA; BRONCHIECTASIS; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC SINUSITIS; CILIARY DYSKINESIA; CONNECTIVE TISSUE DISEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE MARKER; DRUG RESPONSE; EOSINOPHILIA; EXPIRED AIR; HEPATOPULMONARY SYNDROME; HOST RESISTANCE; INFLAMMATION; INTERSTITIAL LUNG DISEASE; OXYGENATION; PATIENT COMPLIANCE; RESPIRATORY FUNCTION; RESPIRATORY TRACT DISEASE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASODILATATION;

ASTHMA; BIOLOGICAL MARKERS; BRONCHIAL HYPERREACTIVITY; BRONCHIECTASIS; EXHALATION; HEPATOPULMONARY SYNDROME; HUMANS; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; RESPIRATORY TRACT DISEASES; SINUSITIS;

EID: 30944460886     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Gustafsson LE, Leone A, Persson MG, Wiklund N, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181: 852-7.
2. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368-70.
3. Guo FH, Comhair SA, Zheng S, et al. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol 2000; 164: 5970-80.
4. American Thoracic Society Official Statement. Recommendations for a standardized procedure for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 1999; 160; 2104-17.
5. Narang I, Ersu R, Wilson NM, Bush A. Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax 2002; 57: 586-9.
6. Kharitonov SA, Gonio F, Kelly C, Meah S, Barnes PJ. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003; 21: 433-8.
7. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute: Global Initiative for asthma: global strategy for asthma management and prevention, NIH Pub No 02-3659, Bethesda, 2002, NIH
8. Silkoff PE, Carlson M, Bourke T, et al. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol 2004; 114: 1241-56.
9. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthma patients. Lancet 1994; 343: 133-5.
10. Frank TL, Adisesh A, PickeringAC, et al. Relationship between exhaled nitric oxide and childhood asthma. Am J Respir Crit Care Med 1998; 158: 1032-6.
11. Al-Ali MK, Howarth PH. Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia. Saudi Med J 2001; 22: 249-53.
12. Salmone C, Roberts A, Brown N, Dermand J, Marks G, Woolcock A. Exhaled nitric oxide measurements in a population sample of young adults. Am J Respir Crit Care Med 1999; 159: 911-6.
13. Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998; 157: 894-8.
14. Silvestri M, Spallarossa D, Battistini E, Brusasco V, Rossi GA. Dissociation between exhaled nitric oxide and hyperresponsiveness in children with mild intermittent asthma. Thorax 2000; 55: 484-8.
15. Gronke L, Kanniess F, Holz O, Jorres RA, Magnussen H. The relationship between airway hyperresponsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease. Clin Exp Allergy 2002; 32: 57-63.
16. deMeer G, Heederik D, Postma DS. Bronchial responsiveness to adenosine 5′-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV-1. Am J Respir Crit Care Med 2002; 165: 327-31.
17. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53: 91-5.
18. Jatakanon A, Lims, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000; 161: 64-72.
19. Rolla G, Di Emanuele A, Dutto L, Marsico P, Nebiolo F, Corradi F, Brussino L, Bucca C. Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin inducible asthma. Allergy 2004; 59: 827-32.
20. Kharitonov SA, Donnelly LE, Corradi M, Montuschi P, Barnes PJ. Dose-dependent onset and duration of action of 100/400 μg budesonide on exhaled nitric oxide and related changes in other potential markers of airway inflammation in asthma. Eur Respir J 2000; 16 (Suppl 31): 3405.
21. Silkoff PE, McClean P, Spino M, Erlich L, Slutsky AS, Zamel N. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001; 119: 1322-8.
22. Jones SL, Herbison P, Cowan JO, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 2002; 20: 601-8.
23. Bisgaard H, Loland L, Oj JA. NO in exhaled air of asthmatic children is reduced by leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med 1999; 160: 1227-31.
24. Ghiro L, Zanconato S, Rampon O, Piovan V, Pasquale MF, Baraldi E. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children. Eur Respir J 2002; 20: 630-4.
25. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001; 164: 738-43.
26. Pijnenburg MW, Hofhuis W, Hop WC, De Jongste JC. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005; 60: 215-8.
27. Delen FM, Sippel JM, Osborne ML, Law S, Thukkani N, Holden WE. Increased exhaled nitric oxide in chronic bronchitis: comparison with asthma and COPD. Chest 2000; 117: 695-701.
28. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 998-1002.
29. Clini E, Cremona G, Campana M, et al. Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-Doppler assessment. Am J Respir Crit Care Med 2000; 162: 446-50.
30. Fabbri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 418-24.
31. Tsang KW, Leun R, Fung PC, Chan SL, Tipoe GL, Ooi GC, Lam WK. Exhaled and sputum nitric oxide in bronchiectasis: correlation with clinical parameters. Chest 2002; 121: 88-94.
32. Wang CH, Liu CY, Lin HC, Yu CT, Chung KF, Kuo HP. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J 1998; 11: 809-15.
33. Morissey BM, Schilling K, Weil JV, Silkoff PE, Rodman DM. Nitric oxide and protein nitration in the cystic fibrosis airway. Arch Biochem Biophys 2002; 406: 33-9.
34. Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003; 123: 751-6.
35. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, Taylor DR. Diagnosing asthma. Comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004; 169: 473-8.
36. Chatkin JM, Ansarin K, Silkoff PE, McLean P, Gutierrez C, Zamel N, Chapman KR. Exhaled nitric oxide as a non-invasive assessment of chronic cough. Am J Respir Crit Care Med 1999; 159: 1810-2.
37. Oates JC, Ruiz P, Alexander A, Pippen AM, Gilkeson GS. Effect of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopathol 1997; 83: 86-92.
38. Belmont HM, Levartovsky D, Goel A, Amin A, Giorno R, Redsike J, et al. Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1810-6.
39. Rolla G, Brussino L, Bertero MT, Colagrande P, Converso M, Bucca C, et al. Increased nitric oxide in exhaled air of patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 1066-71
40. Ludviksdottir D, Janson C, Högman M, et al. Increased nitric oxide in expired air in patients with Sjögren's syndrome. Eur Respir J 1999; 13: 739-43.
41. Kharitonov SA, Cailes JB, Black CM, duBois RM, Barnes PJ. Decreased nitric oxide in exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997; 52: 1051-5.
42. Rolla G, Colagrande P, Scappaticci E, et al. Exhaled nitric oxide in systemic sclerosis: relationship with lung involvement and pulmonary hypertension. J Rheumatol 2000; 27: 1693-8.
43. Paredi P, Kharitonov SA, Loukides S, Pantelidis P, duBois RM, Barnes PJ. Exhaled nitric oxide is increased in active fibrosing alveolitis. Chest 1999; 115: 1352-6.
44. Moodley YP, Chetty R, Lalloo UG. Nitric oxide levels in exhaled air and inducible nitric oxide synthase immunolocalization in pulmonary sarcoidosis. Eur Respir J 1999; 14: 822-7.
45. O'Donnell DM, Moynihan J, Finlay GA, et al. Exhaled nitric oxide and bronchoalveolar nitrite/nitrate in active pulmonary sarcoidosis. Am J Respir Crit Care Med 1997; 156: 1892-6.
46. Rodriguez-Roisin R, Krowka MJ, Hervé Ph, Fallon MB on behalf of the PHD-ERS Task Force Scientific Committee (Rolla G). Pulmonary-Hepatic vascular disorders (PHD) ERS Task Force. Eur Respir J 2004; 24: 861-880.
47. Luo B, Liu L, Tang L, et al. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 2003; 38: 556-63.
48. Rabiller A, Nunes H, Lebrec D , et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 2002; 166: 517-22.
49. Rolla G, Bucca C, Brussino L. Methylene blue in hepatopulmonary syndrome. N Engl J Med 1994; 31: 1098.
50. Brussino L, Bucca C, Morello M, Scappaticci E, Mauro M, Rolla G. Improvement of dyspnea and hypoxemia by inhaled L-NAME in hepatopulmonary syndrome. Lancet 2003; 362: 43-4.
51. Matsumoto A, Ogura H, Hirata Y, et al. Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis. Ann Intern Med 1995; 123: 110-3.
52. Rolla G, Brussino L, Colagrande P, et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology 1997; 26: 842-7.
53. Delclaux C, Mahut B, Zerah-Lancner F, et al. Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma. Am J Respir Crit Care Med 2002; 165: 332-7.
54. Rolla G, Brussino L, Scappaticci E, Morello M, Innarella R, Rosina F, Bucca C. Source of exhaled nitric oxide in primari biliary cirrhosis. Chest 2004; 126: 1546-51.
55. Rolla G, Brussino L, Colagrande P, et al. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med 1998; 129: 375-8.
56. Rolla G. Hepatopulmonary syndrome: role of nitric oxide and clinical aspects. Dig Liver Disease 2004; 36: 303-8.